Who owns Y Mabs Therapeutics Inc?
- Ticker: YMAB
- CUSIP Number: 984241109
Tip: Access positions for across all investors
Analyze quarterly positions in Y Mabs Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Y Mabs Therapeutics stock
Who bought or sold Y Mabs Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 2.2M | $15M | 1% | Dec 2023 |
|
| D. E. Shaw & Co | 1.3M | $9.0M | -2% | Dec 2023 |
|
| Caligan Partners | 1.0M | $7.2M | 4396% | Dec 2023 |
|
| Goldman Sachs Group | 398k | $2.7M | 2% | Dec 2023 |
|
| Dimensional Fund Advisors | 313k | $2.1M | 30% | Dec 2023 |
|
| Jacobs Levy Equity Management | 253k | $1.7M | -52% | Dec 2023 |
|
| Charles Schwab Investment Management | 248k | $1.7M | -1% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 170k | $1.2M | -8% | Dec 2023 |
|
| Two Sigma Advisers | 165k | $1.1M | -18% | Dec 2023 |
|
| Soleus Capital Management | 157k | $1.1M | 0% | Dec 2023 |
|
| Citadel Advisors | 141k | $964k | -66% | Dec 2023 |
|
| Thomas Stevens, CFA" | 128k | $2.1M | -64% | Mar 2024 |
|
| Bank of New York Mellon | 120k | $818k | 0% | Dec 2023 |
|
| Marshall Wace | 115k | $783k | 16% | Dec 2023 |
|
| Rice Hall James & Associates | 86k | $1.4M | 1% | Mar 2024 |
|
| Massachusetts Financial Services | 80k | $543k | -3% | Dec 2023 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 79k | $536k | -12% | Dec 2023 |
|
| State of Wisconsin Investment Board | 77k | $525k | -24% | Dec 2023 |
|
| New York Life Investment Management | 69k | $470k | -3% | Dec 2023 |
|
| Alliancebernstein | 63k | $428k | -19% | Dec 2023 |
|
| Two Sigma Investments | 62k | $422k | -15% | Dec 2023 |
|
| Rhumbline Advisers | 54k | $368k | -2% | Dec 2023 |
|
| Barclays | 50k | $344k | 700% | Dec 2023 |
|
| Federated Investors | 45k | $303k | 4708% | Dec 2023 |
|
| Sapient Capital | 44k | $711k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 41k | $282k | 27% | Dec 2023 |
|
| Cubist Systematic Strategies | 37k | $253k | 2% | Dec 2023 |
|
| UBS Group | 37k | $251k | 88% | Dec 2023 |
|
| Bank of America Corporation | 37k | $249k | 6% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 35k | $240k | 161% | Dec 2023 |
|
| Jane Street | 32k | $220k | 100% | Dec 2023 |
|
| Trexquant Investment | 29k | $195k | -63% | Dec 2023 |
|
| Mirae Asset Global Investments | 26k | $178k | 4% | Dec 2023 |
|
| SG Americas Securities | 22k | $147k | 17% | Dec 2023 |
|
| Millennium Management | 21k | $144k | -94% | Dec 2023 |
|
| MetLife Investment Advisors | 20k | $137k | 0% | Dec 2023 |
|
| T. Rowe Price Associates | 20k | $133k | 7% | Dec 2023 |
|
| Exchange Traded Concepts | 19k | $309k | -32% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 19k | $127k | 3% | Dec 2023 |
|
| American International | 18k | $125k | 0% | Dec 2023 |
|
| Russell Investments | 17k | $116k | -36% | Dec 2023 |
|
| Bailard | 17k | $115k | 100% | Dec 2023 |
|
| Franklin Resources | 16k | $107k | 0% | Dec 2023 |
|
| Cim Investment Mangement | 15k | $104k | 0% | Dec 2023 |
|
| Principal Financial Group | 15k | $101k | -3% | Dec 2023 |
|
| Florida State Board of Administration | 15k | $100k | 0% | Dec 2023 |
|
| ADAR1 Capital Management | 13k | $89k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 10k | $71k | 27% | Dec 2023 |
|
| Royal Bank of Canada | 10k | $71k | 90% | Dec 2023 |
|
| Avestar Capital | 10k | $68k | 0% | Dec 2023 |
|
| Point72 Middle East FZE | 7.4k | $50k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 6.2k | $43k | 0% | Dec 2023 |
|
| Citigroup | 6.0k | $41k | 31537% | Dec 2023 |
|
| Ohio Pers | 5.3k | $36k | -67% | Dec 2023 |
|
| China Universal Asset Management | 5.1k | $34k | 100% | Dec 2023 |
|
| Legal & General Group | 3.7k | $25k | 9% | Dec 2023 |
|
| Summit Investment Advisors | 2.6k | $18k | 0% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 2.1k | $14k | 0% | Dec 2023 |
|
| Simplex Trading | 1.6k | $10k | 94% | Dec 2023 |
|
| Amalgamated Bank | 1.2k | $20k | -70% | Mar 2024 |
|
| HighMark Wealth Management | 220.00 | $1.5k | 0% | Dec 2023 |
|
| CWM | 66.00 | $999.999000 | 2% | Mar 2024 |
|
| Eagle Bay Advisors | 50.00 | $341.000000 | 0% | Dec 2023 |
|
| NISA Investment Advisors | 40.00 | $273.000000 | 0% | Dec 2023 |
|
| GAMMA Investing | 26.00 | $422.999200 | 100% | Mar 2024 |
|
| Farther Finance Advisors | 1.00 | $7.000000 | 100% | Dec 2023 |
|
Who sold out of Y Mabs Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AQR Capital Management | Sep 2023 | 246k | $1.3M |
| GSA Capital Partners | Sep 2023 | 137k | $748k |
| Victory Capital Management | Sep 2023 | 110k | $597k |
| Point72 Asset Management | Sep 2023 | 80k | $434k |
| Algert Coldiron Investors | Sep 2023 | 27k | $145k |
| Man Group | Sep 2023 | 22k | $120k |
| Jump Financial | Sep 2023 | 19k | $103k |
| Denali Advisors | Dec 2023 | 16k | $112k |
| Lazard Asset Management | Sep 2023 | 12k | $67k |
| Corton Capital | Sep 2023 | 12k | $67k |
| Strengthening Families & Communities | Sep 2023 | 1.7k | $9.0k |
| IFP Advisors | Sep 2023 | 103.00 | $560.999800 |
| Allspring Global Investments Holdings | Dec 2023 | 46.00 | $312.997800 |
| State of Wyoming | Sep 2023 | 15.00 | $82.000500 |